HLA-C and neoplasm: Nanoscale artificial APCs (aAPC) carry MHC molecules thus helping to form more MHC-antigen peptide complexes for TCR recognition, to improve the presentation of tumor antigens and promote T cell activation, which in turn stimulate tumor antigen-specific immune responses (19).